ADA: Novel Insulin as Effective as Lantus (CME/CE)

SAN FRANCISCO (MedPage Today) -- A new insulin glargine product proved to be noninferior to the top-selling Lantus in patients with type 1 and type 2 diabetes, researchers reported here.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news